Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice

Journal of Neuroscience

Volumn 22, Issue 22, 2002, Pages 10039-10045

  Rocha, Beatriz A ^a,b   Goulding, Evan H ^c   O'Dell, Laura E ^d   Mead, Andy N ^a   Coufal, Nicole G ^c   Parsons, Loren H ^d   Tecott, Laurence H ^c  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Behavior; Cocaine; Mice; Reinforcement; Serotonin; Serotonin 2c receptor

Indexed keywords

COCAINE; DOPAMINE; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN 2C RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; COCAINE DEPENDENCE; DOPAMINE RELEASE; DRUG DEPENDENCE; LOCOMOTION; MALE; MOUSE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; SEROTONINERGIC SYSTEM;

EID: 0037111849     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-22-10039.2002     Document Type: Article

References (66)

1. Azmitia EC, Segal M (1978) An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 179:641-668.
2. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mossner R, Westphal H, Lesch KP (1998) Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ("ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol 53:649-655.
3. Benuck M, Lajtha A, Reith MEA (1987) Pharmacokinetics of systemically administered cocaine and locomotor stimulation in mice. J Pharmacol Exp Ther 243:144-149.
4. Bhat RV, Baraban JM (1993) Activation of transcription factor genes in striatum by cocaine: Role of both serotonin and dopamine systems. J Pharmacol Exp Ther 267:496-505.
5. Brodie MS, Bunney EB (1996) Serotonin potentiates dopamine inhibition of ventral tegmental area neurons in vitro. J Neurophysiol 76:2077-2082.
6. 2C receptors. J Pharmacol Exp Ther 274:1414-1424.
7. Cameron DL, Williams JT (1994) Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J Neurosci 14:6763-6767.
8. Carroll ME, Lac ST, Asencio M, Kragh R (1990) Intravenous cocaine self-administration is reduced by dietary I-tryptophan. Psychopharmacology 100:293-300.
9. Cloninger CR (1987) A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry 44:573-588.
10. Cloninger CR, Sigvardsson S, Przybeck TR, Svrakic DM (1995) Personality antecedents of alcoholism in a national area probability sample. Eur Arch Psychiatry Clin Neurosci 245:239-244.
11. Cools AR, Brachten R, Heeren D, Willemen A, Ellenbroek B (1990) Search after neurobiological profile of individual-specific features of Wistar rats. Brain Res Bull 24:49-69.
12. Di Giovanni G, De Deurwaerdére P, Di Mascio M, Di Matteo V, Esposito E, Spampinato U (1999) Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: A combined in vivo electrophysiological and microdialysis study. Neuroscience 91:587-597.
13. Di Giovanni G, Di Matteo V, Di Mascio M, Esposito E (2000) Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: A combined in vivo electrophysiological and microdialysis study. Synapse 35:53-61.
14. Di Giovanni G, Di Matteo V, La Grutta V. Esposito E (2001) m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors. Neuroscience 103:111-116.
15. Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E (2000) Biochemical and electrophysiologicai evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors, Brain Res 865:85-90.
16. Dray A, Davies J, Oakley NR, Tongroach P, Vellucci S (1978) The dorsal and medial raphe projections to the substantia nigra in the rat: Electrophysiological, biochemical and behavioural observations. Brain Res 151:431-442.
17. Eberle-Wang K, Mikeladze Z, Uryu K, Chesselet M-F (1997) Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats. J Comp Neurol 384:233-247.
18. Epstein JF (2000) Substance Dependence, abuse and treatment: Findings from the 2000 National Household Survey on Drug Abuse. Rockville, MD: United States Department of Health and Human Services, Substance Abuse and Mental Health Services Administration Office of Applied Statistics.
19. Filip M, Cunningham KA (2002) Serotonin 5-HT(2C) receptors in the nucleus accumbens regulate expression of the hyperlocomotor and discriminative stimulus effects of cocaine. Pharmacol Biochem Behav 71:745-756.
20. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG (1999) Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397-401.
21. Geyer MA, Puerto A, Dawsey WJ, Knapp S, Bullard WP, Mandell AJ (1976a) Histologic and enzymatic studies of the mesolimbic and mesostriatal serotonergic pathways. Brain Res 106:241-256.
22. Geyer MA, Puerto A, Menkes DB, Segal DS, Mandell AJ (1976b) Behavioral studies following lesions of the mesolimbic and mesostriatai serotonergic pathways. Brain Res 106:257-270.
23. Gobert A, Rivet JM, Lejeune F, Newman-Tancredi A, Adhumeau-Auclair A, Nicolas JP, Cistarelli L, Melon C, Millan MJ (2000) Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat. Synapse 36:205-221.
24. Grottick AJ, Fletcher PJ, Higgins GA (2000) Studies to investigate the role of 5-HT2C receptors on cocaine- and food-maintained behavior. J Pharmacol Exp Ther 295:1183-1191.
25. Heisler LK, Tecott LH (2000) A paradoxical locomotor response in serotonin 5-HT2C receptor mutant mice. J Neurosci 20:RC71:1-5.
26. Heisler LK, Chu HM, Brennan T, Danao J, Bajwa P, Parsons L, Tecott LH (1998) Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci USA 95:15049-15054.
27. Herges S, Taylor DA (1999) Modulatory effect of p-chlorophenylalanine microinjected into the dorsal and median raphe nuclei on cocaine-induced behaviour in the rat. Eur J Pharmacol 374:329-340.
28. Herve D, Simon H, Blanc G, Lisoprawski A, Le Moal M, Glowinski J, Tassin JP (1979) Increased utilization of dopamine in the nucleus accumbens but not in the cerebral cortex after dorsal raphe lesion in the rat. Neurosci Lett 15:127-133.
29. Herve D, Pickel VM, Tong HJ, Beaudet A (1987) Serotonin axon terminals in the ventral tegmental area of the rat: Fine structure and synaptic input to dopaminergic neurons. Brain Res 435:71-83.
30. Hooks MS, Kalivas PW (1995) The role of mesoaccumbens-pallidal circuitry in novelty-induced behavioral activation. Neuroscience 64:587-597,
31. Hooks MS, Jones GH, Smith AD, Neill DB, Justice Jr JB (1991) Response to novelty predicts the locomotor and nucleus accumbens dopamine response to cocaine. Synapse 9:121-128.
32. Johnson SW, Mercuri NB, North RA (1992) 5-HydroxytryptaminelB receptors block the GABAB synaptic potential in rat dopamine neurons. J Neurosci 12:2000-2006.
33. Kankaanpää A, Lillsunde P, Ruotsalainen M, Ahtee L, Seppfâlä T (1996) 5-HT3 receptor antagonist MDL 72222 dose-dependently attenuates cocaine- and amphetamine-induced elevations of extracellular dopamine in the nucleus accumbens and the dorsal striatum. Pharmacol Toxicol 78:317-321.
34. Kelland MD, Freeman AS, Rubin J, Chiodo LA (1993) Ascending afferent regulation of rat midbrain dopamine neurons. Brain Res Bull 31:539-546.
35. Koe BK (1976) Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199:649-661.
36. Kranzler HR, Amin H, Modesto-Lowe V, Oncken C (1999) Pharmacologic treatments for drug and alcohol dependence. Psychiatr Clin North Am 22:401-423.
37. Kühn KU, Meyer K, Nöthen MM, Gänsicke M, Papassotiropoulos A, Maier W (1999) Allelic variants of dopamine receptor D4 (DRD4) and serotonin receptor 5HT2c (HTR2c) and temperament factors: Replication tests. Am J Med Genet 88:168-172.
38. Lacosta S, Roberts DC (1993) MDL 72222, ketanserin, and methysergide pretreatments fail to alter breaking points on a progressive ratio schedule reinforced by intravenous cocaine. Pharmacol Biochem Behav 44:161-165.
39. Loh EA, Roberts DCS (1990) Break-points on a progressive ration schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology 101:262-266.
40. Lyness WH, Moore KE (1981) Destruction of 5-hydroxytryptaminergic neurons and the dynamics of dopamine in nucleus accumbens septi and other forebrain regions of the rat. Neuropharmacology 20:327-334.
41. Marinelli M, White FJ (2000) Enhanced vulnerability to cocaine selfadministration is associated with elevated impulse activity of midbrain dopamine neurons. J Neurosci 20:8876-8885.
42. McCreary AC, Cunningham KA (1999) Effects of the 5-HT2C/2B antagonist SB 206553 on hyperactivity induced by cocaine. Neuropsychopharmacology 20:556-564.
43. McMahon LR, Filip M, Cunningham KA (2001) Differential regulation of the mesoaccumbens circuit by serotonin 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors. J Neurosci 21:7781-7787.
44. Morrow BA, Roth RH (1996) Serotonergic lesions alter cocaine-induced locomotor behavior and stress-activation of the mesocorticolimbic dopamine system. Synapse 23:174-181.
45. Parks CL, Robinson PS, Sibille E, Shenk T, Toth M (1998) Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad Sci USA 95:10734-10739.
46. Parsons LH, Justice Jr JB (1994) Quantitative approaches to in vivo brain microdialysis. Crit Rev Neurobiol 8:189-220.
47. Parsons LH, Koob GF, Weiss F (1995) Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Pharmacol Exp Ther 274:1182-1191.
48. Parsons LH, Weiss F, Koob GF (1998) SerotoninlB receptor stimulation enhances cocaine reinforcement. J Neurosci 18:10078-10089.
49. Parsons LH, Kerr TM, Tecott LH (2001) 5-HT1A receptor mutant mice exhibit enhanced tonic, stress-induced and fluoxetine-induced serotonergic neurotransmission. J Neurochem 77:607-617.
50. Peltier RL, Emmett-Oglesby MW, Thomas WH, Schenk S (1994) Failure of ritanserin to block the discriminative or reinforcing stimulus effects of cocaine. Pharmacol Biochem Behav 48:473-478.
51. Piazza PV, Demineire JM, Le Moal M, Simon H (1989) Factors that predict individual vulnerability to amphetamine self-administration. Science 245:1511-1513.
52. Prisco S, Esposito E (1995) Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area. Br J Pharmacol 116:1923-1931.
53. Ramboz S, Oosting R, Amara DA, Kung HF, Blier P, Mendelsohn M, Mann JJ, Brunner D, Hen R (1998) Serotonin receptor 1A knockout: An animal model of anxiety-related disorder. Proc Natl Acad Sci USA 95:14476-14481.
54. Reith ME, Li MY, Yan QS (1997) Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers. Psychopharmacology 134:309-317.
55. Robledo P, Koob GF (1993) Two discrete nucleus accumbens projection areas differentially mediate cocaine self-administration in the rat. Behav Brain Res 55:159-166.
56. Rocha BA, Scearce-Levie K, Lucas JJ, Hiroi N, Castanon N, Crabbe JC, Nestler EJ, Hen R (1998a) Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature 393:175-178.
57. Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, Giros B, Miller GW, Caron MG (1998b) Cocaine self-administration in dopamine-transporter knockout mice. Nat Neurosci [Erratum (1998) 1:330] 1:132-137.
58. Sora I, Hall FS, Andrews AA, Itokawa M, Li X-F, Wei H-B, Wichems C, Lesch K-P, Murphy DL, Uhl GR (2001) Molecular mechanisms of cocaine reward: Combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci USA 98:5300-5305.
59. Strang J, Johns A, Caan W (1993) Cocaine in the UK-1991. Br J Psychiatry 162:1-13.
60. Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF, Julius D (1995) Eating disorder and epilepsy in mice lacking 5HT2C serotonin receptors. Nature 374:542-546.
61. Van Bockstaele EJ, Cestari DM, Pickel VM (1994) Synaptic structure and connectivity of serotonin terminals in the ventral tegmental area: Potential sites for modulation of mesolimbic dopamine neurons. Brain Res 647:307-322.
62. Van Bockstaele EJ, Chan J, Pickel VM (1996) Pre- and postsynaptic sites for serotonin modulation of GABA-containing neurons in the shell region of the rat nucleus accumbens. J Comp Neurol 371:116-128.
63. Wills TA, Vaccaro D, McNamara G (1994) Novelty seeking, risk taking, and related constructs as predictors of adolescent substance use: An application of Cloninger's theory. J Subst Abuse 6:1-20.
64. Wise RA (1984) Neural mechanism of the reinforcing action of cocaine. NIDA Res Monogr 50:15.
65. Withers NW, Pulvirenti L, Koob GF, Gillin JC (1995) Cocaine abuse and dependence. J Clin Psychopharmacol 15:63-78.
66. Zhuang X, Oosting RS, Jones SR, Gainetdinov RR, Miller GW, Caron MG, Hen R (2001) Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc Natl Acad Sci USA 98:1982-1987.